TX-Serum

TX-Serum

Brand: Dr.Melaxin
36.16 USD In stock Buy at Merchant

โœจ Tranexamic Acid Brightening Serum for Melasma & Hyperpigmentation Care: Formulated with Tranexamic Acid (43,010ppm) and Niacinamide to help care for freckles, melasma, pigmentation concerns, and uneven skin tone. ๐Ÿงช Nano Tranexamic Acid (TX) Technology: Features Tranexamic Acid delivered through a nano-liposome system designed to disperse the ingredient into smaller particles for targeted skin delivery. ๐Ÿ”ฌ Patented Tranexamic Acid-Peptide Complex: Contains a patented Tranexamic Acid-Peptide ingredient developed for skin brightening applications and registered under a patented whitening technology. ๐ŸŒŸ Tranexamic Acid + Niacinamide Combination: Formulated with a combined concentration of Tranexamic Acid and Niacinamide (8.6%) to support care for pigmentation-prone areas and overall skin tone concerns. ๐Ÿ“ˆ Whitening Activity Research: Research associated with Patent No. 10-1848887 reported that a cream containing Tranexamic Acid-Peptide demonstrated higher whitening activity than comparison formulas containing Tranexamic Acid alone. ๐Ÿ“Š Melanin Index Improvement Research: In research referenced by the brand, a formula containing Tranexamic Acid-Peptide showed a 23.9% reduction in melanin index after 8 weeks. ๐Ÿ’ง Topical Tranexamic Acid Formula: Developed as a topical ampoule format designed to deliver Tranexamic Acid directly to the skin. ๐Ÿ… Functional Cosmetic Certifications: Whitening functional cosmetic certification Wrinkle-improvement functional cosmetic certification ๐Ÿงด Testing Completed: Hypoallergenic test completed Dermatological testing completed ๐Ÿ“ How To Use: After cleansing and toning, apply an appropriate amount evenly to the face and gently pat to aid absorption. โœ” Suitable For: Skin concerned with melasma, freckles, hyperpigmentation, uneven skin tone, dark spots, and overall brightening care.

Variants (1)
  • Default Title โ€” 36.16 USD โ€” In stock

AI Readiness

Good foundation, but some important product data is still missing.

73%